Materials and methods: The REVISE study, a cross-sectional online survey of 600 participants with T2DM (n = 300 UK, n = 300 US), elicited general preferences for once-daily oral versus once-weekly injectable diabetes medications, and reasons for their preference. Participants then viewed two ...
Higher rates of persistence and adherence in patients with type 2 diabetes initiating once-weekly vs daily injectable glucagon-like peptide-1 receptor agonists in US clinical practice (STAY Study). Diabetes Ther. 2022;13(1):175-187. doi:10.1007/s13300-021-01189-6PubMedGoogle ScholarCross...
Patients' preferences for once-daily oral versus once-weekly injectable diabetes medications: The REVISE study Aims:To understand patient preferences for once-daily oral versus once-weekly injectable type 2 diabetes mellitus (T2DM) medication administration profiles... K Boye,M Ross,R Mody,... - ...
However, anti-obesity medications are generally less efficacious in people with type 2 diabetes, resulting in less bodyweight reduction compared with people without diabetes. We searched PubMed on Jan 16, 2023, using the terms “glucose-dependent insulinotropic polypeptide receptor agonist”, “...
Many of the medications used in the treatment of type-2 diabetes can be used in combination with various other oral therapies to achieve better glycemic control. Some can be given once weekly, an option that provides an avenue to limit polypharmacy and noncompliance, which otherwise may not ...
NDA Accepted for OnceWeekly Injectable Diabetes DrugJody A. Charnow, Editor
doi:10.1016/j.jval.2020.08.022K. BoyeM. RossR. ModyM. KonigH. GelhornValue in Health
Glucagon-like peptide-1 (GLP-1) receptor agonists are often recommended as part of combination therapy for type 2 diabetes when oral medication does not result in sufficient glycemic control. Several GLP-1 receptor agonists are available as weekly injections. These medications vary in their ...
Aims/hypothesisIL-2 injections are a promising therapy for autoimmune type 1 diabetes but the short half-life of this cytokine in vivo limits effective tissue exposure and necessitates frequent injections. Here we have investigated whether an injectable hydrogel could be used to promote prolonged IL...
Results were consistent when adjusted for background antihyperglycaemic medications and diabetes duration. ConclusionsThis network meta-analysis did not identify meaningful differences in HbA1c lowering between ExQW and both liraglutide doses, suggesting that these GLP-1 RAs have similar glycaemic effects...